Amyloid aggregation of lysozyme: The synergy study of red wine polyphenols
暂无分享,去创建一个
Z. Gazova | M. Nagy | K. Siposova | P. Mučaji | E. Kurin
[1] G. Pasinetti,et al. Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] A. Atanasov,et al. Synergy Study of the Inhibitory Potential of Red Wine Polyphenols on Vascular Smooth Muscle Cell Proliferation , 2012, Planta Medica.
[3] S. Martín-Aragón,et al. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. , 2011, Life sciences.
[4] J. Dordick,et al. Polyphenolic Glycosides and Aglycones Utilize Opposing Pathways To Selectively Remodel and Inactivate Toxic Oligomers of Amyloid β , 2011, Chembiochem : a European journal of chemical biology.
[5] Aurélien Grosdidier,et al. SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..
[6] P. Williams,et al. Natural products as a source of Alzheimer's drug leads. , 2011, Natural product reports.
[7] Sunan Wang,et al. Synergistic, additive, and antagonistic effects of food mixtures on total antioxidant capacities. , 2011, Journal of agricultural and food chemistry.
[8] T. Walle. Bioavailability of resveratrol , 2011, Annals of the New York Academy of Sciences.
[9] P. Aracena-Parks,et al. Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects. , 2010, Chemico-biological interactions.
[10] Chin-Giaw Lim and Mattheos A.G. Koffas. Bioavailability and Recent Advances in the Bioactivity of Flavonoid and Stilbene Compounds , 2010 .
[11] M. Masserini,et al. Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. , 2010, Current medicinal chemistry.
[12] A. Masunov,et al. Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer. , 2010, Biophysical chemistry.
[13] J. McLaurin,et al. Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention , 2010, Experimental Neurology.
[14] J. Dordick,et al. Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.
[15] P. Carrupt,et al. Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity* , 2010, The Journal of Biological Chemistry.
[16] A. Murase,et al. Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. , 2009, The American journal of pathology.
[17] Lei Huang,et al. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. , 2009, Neurotoxicology.
[18] A. Falcão,et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. , 2009, Molecular nutrition & food research.
[19] S. Joo,et al. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. , 2009, Life sciences.
[20] Jeong-Yeh Yang,et al. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. , 2008, Life sciences.
[21] R. Quirion,et al. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. , 2008, Mini reviews in medicinal chemistry.
[22] L. Opie,et al. The red wine hypothesis: from concepts to protective signalling molecules. , 2007, European heart journal.
[23] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[24] Kenjiro Ono,et al. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. , 2007, Biochemistry.
[25] Tristan Richard,et al. Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro , 2007 .
[26] E. Gazit,et al. The molecular mechanisms of the anti-amyloid effects of phenols , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[27] Jun Wang,et al. Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] R. Andriantsitohaina,et al. Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. , 2006, Cardiovascular & hematological agents in medicinal chemistry.
[29] Ting-Chao Chou,et al. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.
[30] Christopher M. Dobson,et al. Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.
[31] E. Mandelkow,et al. Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.
[32] Peter Davies,et al. Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.
[33] S. Percival,et al. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. , 2005, Cancer letters.
[34] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[35] Angelo Fontana,et al. A highly amyloidogenic region of hen lysozyme. , 2004, Journal of molecular biology.
[36] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[37] Jia Huang,et al. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. , 2004, Biomacromolecules.
[38] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[39] D. Tagliazucchi,et al. Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin , 2003, Brain Research Bulletin.
[40] Y. Yonezawa,et al. Effects of salt concentration on association of the amyloid protofilaments of hen egg white lysozyme studied by time-resolved neutron scattering. , 2003, Journal of molecular biology.
[41] M. Benson,et al. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. , 2003, Kidney international.
[42] G. Rottinghaus,et al. Resveratrol protects against global cerebral ischemic injury in gerbils , 2002, Brain Research.
[43] S. Ferreira,et al. β-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's Disease , 2002, Cellular and Molecular Neurobiology.
[44] C. Scaccini,et al. Coffee drinking influences plasma antioxidant capacity in humans. , 2002, Journal of agricultural and food chemistry.
[45] Ž. Eva. Amyloid-fibril formation: Proposed mechanisms and relevance to conformational disease , 2002 .
[46] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[47] Ehud Gazit,et al. A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[49] Yun-Lian Lin,et al. The Neuroprotective Effects of Phytoestrogens on Amyloid β Protein-induced Toxicity Are Mediated by Abrogating the Activation of Caspase Cascade in Rat Cortical Neurons* , 2001, The Journal of Biological Chemistry.
[50] C M Dobson,et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.
[51] J. Rajfer,et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. , 1999, Urology.
[52] W. Schaffner,et al. Phytoestrogen kaempferol (3,4′,5,7‐tetrahydroxyflavone) protects PC12 and T47D cells from β‐amyloid–induced toxicity , 1999, Journal of neuroscience research.
[53] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[55] D. Dickstein,et al. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. , 2009, Journal of Alzheimer's disease : JAD.
[56] C. Nerelius. Protein misfolding and amyloid formation , 2009 .
[57] J. Sipe. Amyloid proteins : the beta sheet conformation and disease , 2005 .
[58] S. Ferreira,et al. Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. , 2002, Cellular and molecular neurobiology.
[59] E. Žerovnik,et al. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. , 2002, European journal of biochemistry.